Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT05750589
- Locations
- 🇺🇸
R. Gary Lane, II MD, San Antonio, Texas, United States
SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05747430
- Locations
- 🇺🇸
Edward Wood, MD, Round Rock, Texas, United States
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
Phase 3
Terminated
- Conditions
- Diabetic Macular EdemaGlaucoma/Closed Angle GlaucomaBranch Retinal Vein Occlusion
- Interventions
- Drug: Control
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- iRenix Medical, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT05127525
- Locations
- 🇺🇸
Florida, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath